通过肠肺轴通过罗斯马林酸缓解过敏性喘
Hui-Hui Guo1, Yan-Xing Han1, Xiao-Juan Rong2
1Institute of Materia Medica, Chinese Academy of Medical Sciences & Peking Union Medical College, Beijing, PR China.
概括
迷酸 (RosA) 通过改变肠道细菌,减少炎症和改善肠道屏障功能来缓解喘. 这种天然化合物显示出作为传统喘治疗的安全有效替代品的希望.
科学领域:
- 综合免疫学和药理学综合免疫学和药理学
- 基于微生物组的治疗方法
- 自然产品药物发现自然产品药物发现
背景情况:
- 喘影响全球数百万人,目前的治疗方法面临局限性.
- 由于喘的复杂性和患病率,人们正在寻求替代疗法.
- 罗斯马林酸 (RosA) 是一种天然化合物,具有潜力,但生物可用性不佳.
研究的目的:
- 阐明RosaA通过肠肺轴缓解过敏性喘的机制.
- 调查Rosa对肠道微生物群组成和功能的影响.
- 探索Rosa在喘中影响的药理途径.
主要方法:
- 16S rRNA基因测序和代谢学来分析肠道微生物群.
- 分子生物学技术用于研究Rosa的药理作用.
- 共同安置实验证实了肠道微生物群在Rosa的有效性中的作用.
主要成果:
- RosA调节肠道微生物群,减少胆酸盐和增加短链脂肪酸 (SCFA).
- 这导致了减少5西胺 (5-HT) 合成,支气管收缩和炎症.
- RosA增强了肠道完整性,减少了脂多糖 (LPS) 转移,并抑制了肺炎和氧化应激.
结论:
- 口服Rosa的抗喘作用是由肠道微生物群衍生的5-HT,SCFA和LPS调节的介导.
- 罗萨证明了一种协同机制,改善了肠道屏障功能并减少了全身炎症.
- 罗斯阿是一种有前途,安全和有效的喘治疗候选药物,可能是葡萄糖皮质醇的替代品.
相关概念视频
01:20Asthma: Pathogenesis and Management
396
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
396
01:19Antiasthma Drugs: Leukotriene Modifiers
298
Leukotriene modifiers, or cysteinyl leukotriene receptor antagonists, are medications used to manage chronic asthma. These agents target specific inflammatory mediators produced during arachidonic acid metabolism, an essential process in generating inflammation in the body.
Leukotriene modifiers work through two distinct mechanisms:
Leukotriene modifiers work through two distinct mechanisms:
298
01:25Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs
294
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
294
01:26Asthma-II: Pathophysiology and Classification
2.7K
Asthma is a prevalent chronic respiratory condition marked by inflammation and hyperresponsiveness of the airways. Its pathophysiology involves complex interactions among inflammatory pathways, immune responses, and neural mechanisms.
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
Additionally, environmental and genetic factors play crucial roles in determining an individual's susceptibility to asthma and the severity of their condition.
Critical processes in asthma pathophysiology include:
2.7K
01:17Drugs Used in Lower Respiratory Disorders: Overview
442
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
442
01:25Antiasthma Drugs: β2-Adrenoceptor Agonists
264
Bronchodilators are critical in managing asthma, a chronic respiratory condition characterized by airway constriction due to inflammation and hyper-reactivity. Specifically, bronchodilators ease this constriction by relaxing the bronchial muscles, facilitating easier breathing.
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
One class of bronchodilators includes β2-adrenoceptor agonists. These agents target the β2-adrenoceptors located on bronchial smooth muscle cells. By stimulating these receptors, β2-agonists induce...
264